Results 91 to 100 of about 12,399 (131)

The efficacy and safety of pharmacological treatment for major depressive episode with mixed features specifier: a systematic review and meta-analysis. [PDF]

Psychol Med
Gao S, Chen Y, Liu J, Zhang Q, Zhao X, Liu B, Zhang Y, Li L, Wang G.   +8 more
europepmc   +1 more source

Venetoclax as a cytoreduction therapy option for acute promyelocytic leukemia in newly diagnosed adult patients: a case report of a 35-year-old female with schizophrenia. [PDF]

Front Oncol
Wang L, Miao Y, Cheng Y.
europepmc   +1 more source

Serum Apolipoprotein B Levels and Apolipoprotein B/Apolipoprotein A1 Ratio as Predictors of Dyslipidemia Risk in Patients Treated with Second-Generation Antipsychotics: A Retrospective Cohort Study. [PDF]

Neuropsychiatr Dis Treat
Zhang JX, Huang ZQ, Yang JM, Wang WY, Li WN.   +4 more
europepmc   +1 more source

Antipsychotic-Related Prolactin Changes: A Systematic Review and Dose-Response Meta-analysis. [PDF]

CNS Drugs
Lin X, Siafis S, Tian J, Wu H, Qin M, Correll CU, Schneider-Thoma J, Leucht S.   +7 more
europepmc   +1 more source

Gaps in the detection of drug-drug interactions between antipsychotic and cardiometabolic medications: a multisource analysis. [PDF]

BMC Med
Yao H, Peng Z, Huang Y, Xiao S, Wu R.
europepmc   +1 more source

Identification and Treatment of Catatonia Presenting as Agitation and Self Injury in an Adolescent With Rett Syndrome. [PDF]

Case Rep Psychiatry
Al-Omari A, Mohiuddin S.
europepmc   +1 more source

Anesthetic implications of psychotropic medications: a narrative review. [PDF]

J Yeungnam Med Sci
Jung SM, Park SJ.
europepmc   +1 more source

Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database. [PDF]

Sci Rep
Yin Y, Jiang J, Jin Y.
europepmc   +1 more source